Ovid Therapeutics Q3 EPS $(0.43) Up From $(0.53) YoY

Ovid Therapeutics (NASDAQ:OVID) reported quarterly losses of $(0.43) per share. This is a 18.87 percent increase over losses of $(0.53) per share from the same period last year.

Benzinga · 11/08/2019 13:07

Ovid Therapeutics (NASDAQ:OVID) reported quarterly losses of $(0.43) per share. This is a 18.87 percent increase over losses of $(0.53) per share from the same period last year.